Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration
Articolo
Data di Pubblicazione:
2021
Citazione:
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration / Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P.. - In: BJU INTERNATIONAL. - ISSN 1464-4096. - (2021). [10.1111/bju.15434]
Abstract:
Objectives: To evaluate outcomes of patients achieving a post-treatment pathological stage of
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
#BladderCancer; #blcsm; bladder cancer; neoadjuvant chemotherapy; pathological response; recurrence
Elenco autori:
Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P.
Link alla scheda completa:
Pubblicato in: